A Study Comparing HR17031 With Insulin Glargine in Patients With Type 2 Diabetes

Clinical trial NCT06881264 · COMPLETED

Trial details

NCT number: NCT06881264
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Adult Patients With Type 2 Diabetes Uncontrolled on Oral Antidiabetic Drugs

Start date: 2024-04-30
Primary completion: 2025-09-19
Enrollment: 401

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.